VanEck Associates’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Sell |
3,584
-220
| -6% | -$1.9K | ﹤0.01% | 1341 |
|
|
2025
Q1 | $30K | Buy |
3,804
+343
| +10% | +$2.71K | ﹤0.01% | 1321 |
|
|
2024
Q4 | $31K | Buy |
3,461
+659
| +24% | +$5.9K | ﹤0.01% | 1320 |
|
|
2024
Q3 | $24K | Sell |
2,802
-1,015
| -27% | -$8.69K | ﹤0.01% | 1307 |
|
|
2024
Q2 | $37K | Hold |
3,817
| – | – | ﹤0.01% | 1304 |
|
|
2024
Q1 | $58K | Buy |
3,817
+228
| +6% | +$3.47K | ﹤0.01% | 1274 |
|
|
2023
Q4 | $77K | Buy |
3,589
+606
| +20% | +$13K | ﹤0.01% | 1259 |
|
|
2023
Q3 | $55K | Hold |
2,983
| – | – | ﹤0.01% | 1277 |
|
|
2023
Q2 | $76K | Buy |
2,983
+250
| +9% | +$6.37K | ﹤0.01% | 1269 |
|
|
2023
Q1 | $71K | Sell |
2,733
-152
| -5% | -$3.95K | ﹤0.01% | 1283 |
|
|
2022
Q4 | $68K | Sell |
2,885
-920
| -24% | -$21.7K | ﹤0.01% | 1294 |
|
|
2022
Q3 | $96K | Buy |
3,805
+2,226
| +141% | +$56.2K | ﹤0.01% | 1181 |
|
|
2022
Q2 | $52K | Sell |
1,579
-15,723
| -91% | -$518K | ﹤0.01% | 1284 |
|
|
2022
Q1 | $1.25M | Buy |
17,302
+2,999
| +21% | +$216K | ﹤0.01% | 794 |
|
|
2021
Q4 | $1.31M | Buy |
14,303
+11,437
| +399% | +$1.05M | ﹤0.01% | 797 |
|
|
2021
Q3 | $363K | Sell |
2,866
-7,021
| -71% | -$889K | ﹤0.01% | 952 |
|
|
2021
Q2 | $1.64M | Sell |
9,887
-11,353
| -53% | -$1.89M | ﹤0.01% | 705 |
|
|
2021
Q1 | $3.86M | Buy |
+21,240
| New | +$3.86M | 0.01% | 480 |
|